Related scientific articles (all)

Unravelling the epigenomic dimension of breast cancers.

Authors : Dedeurwaerder S, Fumagalli D, Fuks F
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pages : 559-65

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response.

Authors : Li Q, Eklund AC, Birkbak NJ, Desmedt C, Haibe-Kains B, Sotiriou C, Symmans WF, Pusztai L, Brunak S, Richardson AL, Szallasi Z
Year : 2011
Journal : BMC Bioinformatics
Volume : 12(null)
Pages : 310

Prevention of febrile neutropenia in chemotherapy – treated cancer patients : Pegylated versus standard myeloid colony stimulating factors. Do we have a choice ?

Authors : Klastersky J, Awada A
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 78(1)
Pages : 17-23

Pattern of care in locally advanced breast cancer: focus on local therapy.

Authors : Sinacki M, Badzio A, Welnicka-Jaskiewicz M, Bogaerts J, Piccart-Gebhart M, Therasse P, Smith IE, Hatschek T, Jassem J
Year : 2011
Journal : Breast
Volume : 20(2)
Pages : 145-50

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Authors : Di Leo A, Desmedt C, Bartlett JM, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H
Year : 2011
Journal : Lancet Oncol
Volume : 12(12)
Pages : 1134-42

Is VEGF a predictive biomarker to anti-angiogenic therapy ?

Authors : Otrock ZK, Hatoum HA, Musallam KM, Awada A, Shamseddine AI
Year : 2011
Journal : Crit Rev Oncol Hematol
Volume : 79(2)
Pages : 103-11

A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.

Authors : Schöffski P, Garcia JA, Stadler WM, Gil T, Jonasch E, Tagawa ST, Smitt M, Yang X, Oliner KS, Anderson A, Zhu M, Kabbinavar F
Year : 2011
Journal : BJU Int
Volume : 108(5)
Pages : 679-686

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Authors : Bedard PL, Singhal SK, Ignatiadis M, Bradbury I, Haibe-Kains B, Desmedt C, Loi S, Evans DB, Michiels S, Dixon JM, Miller WR, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : Endocr Relat Cancer
Volume : 18(6)
Pages : 721-30

Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.

Authors : Mattarollo SR, Loi S, Duret H, Zitvogel L, Smyth MJ
Year : 2011
Journal : Cancer Res
Volume : 71(14)
Pages : 4809-20

Small cell carcinoma of the esophagus: a multicentre Rare Cancer Network study.

Authors : Vos B, Rozema T, Miller RC, Hendlisz A, Van Laethem JL, Khanfir K, Weber DC, El Nakadi I, Van Houtte P
Year : 2011
Journal : Dis. Esophagus
Volume : 24(4)
Pages : 258-64

Multiple-input multiple-output causal strategies for gene selection.

Authors : Bontempi G, Haibe-Kains B, Desmedt C, Sotiriou C, Quackenbush J
Year : 2011
Journal : BMC Bioinformatics
Volume : 12(1)
Pages : 458